What are Mission Vision & Core Values of Virbac Company?

Virbac Bundle

Get Full Bundle:

	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

What drives Virbac’s purpose and strategy?

Mission and vision statements steer resource choices, culture, and long-term value in animal health. With the sector growing at 6–8% CAGR, clarity helps prioritize innovation, regulatory excellence, and stewardship across companion animal and livestock care.

Virbac, founded in 1968 and active in over 100 countries, uses its mission and values to shape R&D, portfolio focus (vaccines, parasiticides, dermatology, antibiotics, nutritionals), and partnerships with veterinarians and producers. See Virbac Porter's Five Forces Analysis for strategic context.

Virbac’s mission focuses on global, vet-centric animal health: supplying vaccines, parasiticides, antibiotics, dermatology, nutrition and diagnostics to veterinarians, pet owners and livestock producers with local manufacturing and preventive innovation.

Target customers

Veterinarians, pet owners and livestock producers are prioritized for product development and support.

Core offerings

Vaccines, parasiticides, antibiotics, dermatology, nutrition/immunity products and diagnostics/services form the portfolio.

Global scope

Operations in over 100 countries with regional manufacturing and distribution to address multi-species needs.

Unique value

Independent specialist model with strong dermatology and parasiticide franchises, vet-centric support and local production.

Companion examples

Dermatology lines and parasiticides target preventive care for pets, reinforcing vet-first distribution and welfare outcomes.

Livestock examples

Regional vaccines and antiparasitic programs (e.g., ruminant control in Latin America, poultry/bovine in APAC) support herd-level disease prevention.

Mission summary: Improve animal welfare worldwide via vet-led prevention, research-driven products and local manufacturing—aligning Virbac mission, Virbac vision and Virbac core values to delivery and growth; see Owners & Shareholders of Virbac.

Virbac SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

Virbac vision: advance animal health with innovative, accessible solutions that improve animals' lives and support caregivers, emphasizing preventive care, dermatology, parasiticides and One Health across global markets.

Future orientation

Positions Virbac to expand leadership in preventive care, dermatology and parasiticides while deepening presence in emerging markets.

Scope

Focuses on global impact via science, affordability and veterinary partnerships rather than pure scale dominance.

Realism vs aspiration

With annual revenues near €1.1bn (2024) and targeted growth in dermatology/parasiticides, the vision is aspirational yet credible.

Innovation diffusion

Continued pipeline investment and R&D partnerships aim to accelerate product accessibility and uptake globally.

One Health link

Integrates animal and human well-being through responsible use, zoonosis prevention and veterinary collaboration.

Strategic credibility

Targeted double-digit pockets in growth areas support a realistic path to broader market impact and stakeholder value.

Virbac mission and core values center on science-driven animal health, affordability, veterinary partnership and ethical responsibility, guiding R&D, market access and CSR across its multi-billion-euro operations; see Growth Strategy of Virbac for context.

Virbac PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

Virbac core values guide daily decisions across its global animal-health operations, shaping R&D priorities, regulatory engagement, and field services. These values emphasize science-led innovation, animal welfare, ethical conduct, and local responsiveness to improve animal health outcomes worldwide.

Customer focus and veterinarian partnership

Virbac collaborates with vets and producers to co-develop protocols, deliver medical education, and provide helplines and vet-detailing that improve clinical adoption and dosing compliance.

Innovation and quality

Focused R&D in vaccines, dermatology and parasiticides plus GMP/QA across global plants and pharmacovigilance systems ensure continuous safety and label refinements post-launch.

Responsibility and animal welfare

Emphasis on preventive medicine and stewardship reduces antimicrobial use; welfare-focused formulations (palatability, easier dosing) lower animal stress and improve outcomes.

Integrity, compliance and entrepreneurship

Transparent regulatory engagement with EMA/FDA/ANVISA, strict adverse-event reporting, ethical trials, and decentralized country teams speed launches and adapt portfolios to local needs.

Read how Virbac mission and vision shape strategic choices and R&D investments next; explore examples and KPIs such as R&D spend (~6–8% of revenue in recent years) and global manufacturing footprint that drive execution. Revenue Streams & Business Model of Virbac

Values — Customer focus, Innovation & quality, Responsibility & welfare, Integrity & compliance; examples: vet-detailing and helplines, GMP/QA and pharmacovigilance, stewardship to reduce antimicrobials, regulatory transparency; differentiation: exclusive animal-health focus with localized manufacturing and dermatology leadership.

Virbac Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Mission and vision shape strategic choices by prioritizing animal health, prevention, and global access, guiding R&D, M&A, and market entry decisions. They also drive day-to-day medical affairs, labeling, and partner engagement to align products with long-term welfare and accessibility goals.

Virbac mission, vision & core values

The company's purpose centers on improving animal health through prevention, innovation and global access.

• 6–8% of sales benchmarked to R&D in animal health supports preventive pipeline focus
• Priority areas: vaccines, parasiticides, dermatology and chronic-care formulations
• Expansion focus: APAC and LatAm distribution and local registrations
• Partnerships with vets, associations and universities for trials and CE programs

Mission

The mission emphasizes improving animal health and welfare worldwide by prioritizing preventive and accessible veterinary solutions.

Vision

The vision targets a global leadership role in animal health through innovation, scaled access and stewardship of therapeutic resources.

Core values

Values emphasize animal welfare, scientific rigor, collaboration, integrity and customer-centricity in products and services.

Strategy alignment

Product development and portfolio mix prioritize prevention (vaccines, parasiticides) and dermatology to reflect welfare and accessibility aims.

Market expansion

Investment in APAC and LatAm distribution, plus country-specific portfolios, supports the worldwide mandate and regional disease burdens.

Partnerships & M&A

Collaborations with veterinary associations and targeted acquisitions increase scientific credibility, capacity and supply resilience.

The mission and vision steer near-term tactics and long-term pipeline toward prevention and quality-of-life products, linking purpose to R&D spend, market expansion and vet partnerships; read next: Core Improvements to Company's Mission and Vision — Competitors Landscape of Virbac

Influence — Strategy alignment: Product development: Prioritization of preventive solutions (vaccines, parasiticides) and dermatology reflects the mission’s welfare and accessibility aims. Evidence includes sustained category growth and new formulations that improve adherence.

Market expansion: Investment in APAC/LatAm distribution and local registrations supports the ‘worldwide’ mandate and affordability goals; country-specific parasite/vaccine portfolios address regional burdens.

Partnerships: Collaborations with veterinary associations and universities to run field trials and CE programs extend access and scientific credibility.

Acquisitions/Capex: Selective acquisitions of brands or manufacturing capacity in strategic regions enhance supply resilience and access.

Metrics: Industry benchmarks show animal health firms allocating 6–8% of sales to R&D; dermatology and parasiticide segments often outgrow the market, contributing mid- to high-single-digit company growth; vaccination and prevention uptake correlates with reduced antimicrobial sales in EU food animals since 2011. Day-to-day, the mission informs medical affairs guidance, labeling, and farmer/vet training; long-term, it guides pipeline mix toward prevention and chronic-care quality-of-life products. Leadership messaging frequently links purpose to innovation, access, and veterinary partnership.

Virbac Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔

Four core improvements can sharpen Virbac mission and Virbac vision to be more measurable, sustainability-focused, data-driven and aligned with evolving animal-health markets. These enhancements support clearer Virbac core values and operational KPIs for stakeholders, employees and investors.

Embed measurable, time-bound targets

Define explicit KPIs such as percentage of product portfolio in prevention by 2028, target reduction in CO2e per dose, and annual number of veterinarians trained to turn Virbac mission into quantifiable goals.

Strengthen One Health and sustainability commitments

Commit to antimicrobial stewardship targets (measured reductions in antibiotic use enabled by vaccines and parasite control), sustainable manufacturing milestones, and circular packaging to reflect modern Virbac company purpose and corporate values.

Integrate digital, diagnostics and real‑world evidence

Include tele‑vet services, diagnostic-linked product offerings, precision livestock analytics and real‑world evidence generation to align Virbac vision with technology trends and measurable R&D impact.

Align values with measurable stakeholder outcomes

Translate Virbac core values into employee and supplier KPIs—e.g., diversity targets, R&D spend as percentage of sales, and CSR metrics tied to animal welfare and climate resilience.

• Clarity and measurability: Add explicit, time-bound targets (e.g., percentage of portfolio in prevention by 2028; reduction in CO2e per dose; number of vets trained annually) to translate purpose into KPIs—mirroring best-in-class statements that integrate measurable impact.
• One Health and sustainability: More explicit commitment to antimicrobial stewardship outcomes (e.g., targeted reduction in antibiotic use enabled by vaccines/parasite control), sustainable manufacturing, and circular packaging, reflecting evolving regulatory and stakeholder expectations.
• Digital and data orientation: Incorporate tele-vet, diagnostics, real-world evidence, and precision livestock analytics into the vision to address changing behaviors and technology trends.
• These refinements present growth opportunities to future-proof the mission/vision amid rising pet humanization, consolidation in vet chains, and climate-driven disease shifts.

Relevant metrics to cite: Virbac reported global sales of approximately €1.2 billion in 2024, with R&D investment near 10% of sales in recent years; integrating measurable targets would contextualize Virbac mission statement analysis and Virbac vision and strategic goals for animal health. Read a market-focused analysis at Target Market of Virbac

Implementation of Mission and Vision in Corporate Strategy requires aligning product portfolios, culture and metrics so purpose drives decisions across R&D, commercial and operations. Clear governance and measurable KPIs translate Virbac mission and Virbac vision into daily actions and stakeholder accountability.

Mission, Vision & Core Values Overview

Concise definitions that guide global animal-health strategy, innovation and behavior.

• Mission: improve animal health and welfare through prevention and care
• Vision: be a global leader in accessible, science-driven veterinary solutions
• Core values: animal welfare, scientific rigor, responsibility, proximity to customers
• Purpose: focus on prevention, stewardship and sustainable access

Strategic Focus

R&D and commercial priorities emphasize vaccines, dermatology and preventive care to reduce disease burden and antimicrobial use.

Culture & Leadership

Leadership cascades Virbac corporate values via annual strategy cycles, P&L targets and medical governance tied to access and stewardship metrics.

Commercial Execution

Country-level disease mapping and farmer/veterinarian training guide tailored launches and improve treatment compliance.

Quality & ESG Systems

Global pharmacovigilance, quality systems and ESG dashboards monitor safety, emissions, water and access indicators.

Implementation

• Business initiatives: Expansion of preventive portfolios including vaccines and long-acting parasiticides, plus palatable formulations to boost compliance; country disease mapping informs launches; farmer training and vet CE scale welfare and productivity.
• Leadership reinforcement: Purpose embedded in annual strategy, country P&Ls linked to access/prevention metrics, medical affairs ensuring evidence-based claims and stewardship.
• Communication: Purpose and Virbac core values included in onboarding, code of conduct, sustainability reports and vet materials; digital tools deliver dosing, safety alerts and practice support.
• Systems and programs: Global pharmacovigilance and quality systems; stage-gate R&D with welfare/ESG checkpoints; key account management tracks clinical outcomes; supply-chain risk management and ESG dashboards monitor emissions, water, waste and access.
• Evidence of alignment: Portfolio weighted toward prevention and dermatology, broad vet education programs, responsible-use materials with antimicrobials, and localized manufacturing to keep products affordable and reliable.

Latest facts and metrics: as of 2024 Virbac reported revenues of approximately €1.0 billion, with prevention and dermatology representing a growing share of sales; R&D spend was near 6–7% of revenue and manufacturing footprint includes regional sites to reduce lead times and support local access. See a company background in Brief History of Virbac.